SCHEMBL14797142

SCHEMBL14797142

Cc1csc(Sc2ncc3nc(-c4cc(C)c(OCC(=O)O)c(C)c4)oc3n2)n1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.53
ADORA2A P29274 1/20 0.34
PTPN1 P18031 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
MIF P14174 1/20 0.31
HTT P42858 2/20 0.31
POLB P06746 1/20 0.31
PPARG P37231 2/20 0.30
PPARA Q07869 2/20 0.30
PPARD Q03181 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14796973 0.88 S1PR1 (0.52) S1PR1PTPN1CSNK2A2CSNK2BCSNK2A1
SCHEMBL14797021 0.83 S1PR1 (0.54) S1PR1PTPN1CSNK2A2CSNK2BCSNK2A1
SCHEMBL2147337 0.81 S1PR1 (0.39) S1PR1ADORA2AALDH1A1LMNAPPARG
SCHEMBL14796993 0.74 S1PR1 (0.49) S1PR1PTPN1CSNK2A2CSNK2BCSNK2A1
SCHEMBL15310121 0.74 S1PR1 (0.39) S1PR1
SCHEMBL2223368 0.73 S1PR1 (0.83) S1PR1PTPN1ALDH1A1LMNAMAPK1
SCHEMBL14797017 0.73 S1PR1 (0.73) S1PR1PTPN1ALDH1A1CSNK2A2CSNK2B
SCHEMBL15310012 0.73 S1PR1 (0.38) S1PR1
SCHEMBL14797315 0.73 S1PR1 (0.64) S1PR1PTPN1POLBPPARGPPARA
SCHEMBL2222996 0.72 S1PR1 (0.62) S1PR1PTPN1CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885ADORA2A 90/4885PTPN1 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.